Xu, Guoxiang (1962) 徐國祥
Dealings in Livzon Pharmaceutical Group Inc.: H
Exchange | Code | Listed | Last trade | Delisted | |
---|---|---|---|---|---|
HK Main | 01513 | 2014-01-16 |
Click the date to see more details. L=Long, S=Short. Click the on-exchange price to see the CCASS movements on the settlement date corresponding to the relevant event, for trades after 22-Jun-2007.
Some data are hidden to fit your display. Rotate?
Relevant date Y-M-D |
Probable reason |
L / S |
Shares involved |
CapacityCapacity of the shares involved | Interest in shares |
Curr | OnEx Price |
OffEx Price |
Value | Stake % |
Stake Δ % |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 24-05-13 | Call expExpired right to take underlying shares | L | -48,000 | OwnerBeneficial owner | 895,800 | CNY | 31.310 | -1,502,880 | 0.14 | -0.01 | |
2 | 22-11-23 | CallRight to take underlying shares | L | 160,000 | OwnerBeneficial owner | 943,800 | CNY | 31.310 | 5,009,600 | 0.15 | 0.02 | |
3 | 22-09-27 | Call expExpired right to take underlying shares | L | -76,050 | OwnerBeneficial owner | 783,800 | CNY | 36.160 | -2,749,968 | 0.13 | -0.01 | |
4 | 21-06-11 | ExercisedExercised derivative rights to acquire | L | 76,050 | OwnerBeneficial owner | 859,850 | CNY | 36.160 | 2,749,968 | 0.14 | 0.00 | |
5 | 20-07-01 | ExercisedExercised derivative rights to acquire | L | 101,400 | 859,850 | CNY | 36.160 | 3,666,624 | 0.14 | 0.00 | ||
6 | 19-09-10 | CallRight to take underlying shares | L | 58,500 | OwnerBeneficial owner | 859,850 | 0.14 | 0.01 | ||||
7 | 19-07-03 | GivenReceived shares without payment | L | 139,927 | OwnerBeneficial owner | 801,350 | 0.13 | 0.02 | ||||
8 | 18-09-28 | CallRight to take underlying shares | L | 195,000 | OwnerBeneficial owner | 661,423 | 0.14 | 0.04 | ||||
9 | 18-06-22 | GivenReceived shares without payment | L | 107,636 | OwnerBeneficial owner | 466,423 | 0.10 | 0.00 | ||||
10 | 17-06-30 | AppointedPosition on appointment as director/CE | L | 275,990 | OwnerBeneficial owner | 275,990 | 0.10 | 0.00 |
Sign up for our free newsletter
Recommend Webb-site to a friend
Copyright & disclaimer, Privacy policy